Literature DB >> 20101267

1-Methyl-4-phenyl-pyridinium time-dependently alters expressions of oxoguanine glycosylase 1 and xeroderma pigmentosum group F protein in PC12 cells.

Hong-Mei Liu1, Shan-Zheng Yang, Feng-Yan Sun.   

Abstract

OBJECTIVE: To determine if DNA excision repair enzymes oxoguanine glycosylase 1 (OGG1) and xeroderma pigmentosum group F protein (XPF) are involved in the pathogenesis of Parkinson's disease (PD) in a cell model.
METHODS: PC12 cells were treated with 1-Methyl-4-phenylpyridine ion (MPP(+)) for various periods of time to induce oxidative DNA damage. MTT assay was used to determine cell viability. Immunocytochemistry with antibody against 8-hydroxy-2'-deoxyguanosine (8-oxodG) was used to evaluate oxidative DNA damage. Immunoblotting was used to detect the protein levels of OGG1 and XPF.
RESULTS: MPP(+) treatment (1 mmol/L) for 18 h and 24 h reduced cell viability to 78.6% and 70.3% of the control, respectively, in a time-dependent way. MPP(+) increased the immunoreactivity of 8-oxodG in the cytoplasm at 3 h and in the nucleus at 24 h of treatment. With the treatment of MPP(+), the expression of OGG1 was significantly increased at 1 h, reaching a peak at 3 h, and then it was decreased at 24 h, as compared to that with vehicle treatment. The same effect was exerted on XPF level, except that the XPF level reached a peak at 18 h of MPP(+) treatment. Moreover, the maximally-increased protein level of OGG1 by MPP(+) was approximately 2-fold higher than that of XPF.
CONCLUSION: MPP(+) treatment could time-dependently induce increases in OGG1 and XPF expressions in PC12 cells. Also, this study indicates that the base and nucleotide excision repair pathways may be compensatory activated in the early stage of pathogenesis in the cells after MPP(+) treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20101267      PMCID: PMC5560382          DOI: 10.1007/s12264-010-0922-3

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  29 in total

1.  Expression of 8-oxoguanine DNA glycosylase (OGG1) in Parkinson's disease and related neurodegenerative disorders.

Authors:  Jiro Fukae; Masashi Takanashi; Shin-ichiro Kubo; Ken-ichi Nishioka; Yusaku Nakabeppu; Hideo Mori; Yoshikuni Mizuno; Nobutaka Hattori
Journal:  Acta Neuropathol       Date:  2004-11-17       Impact factor: 17.088

2.  Mitochondrial DNA sequence analysis of four Alzheimer's and Parkinson's disease patients.

Authors:  M D Brown; J M Shoffner; Y L Kim; A S Jun; B H Graham; M F Cabell; D S Gurley; D C Wallace
Journal:  Am J Med Genet       Date:  1996-01-22

3.  The oxidative DNA lesion 8,5'-(S)-cyclo-2'-deoxyadenosine is repaired by the nucleotide excision repair pathway and blocks gene expression in mammalian cells.

Authors:  P J Brooks; D S Wise; D A Berry; J V Kosmoski; M J Smerdon; R L Somers; H Mackie; A Y Spoonde; E J Ackerman; K Coleman; R E Tarone; J H Robbins
Journal:  J Biol Chem       Date:  2000-07-21       Impact factor: 5.157

4.  Up-regulation of hMUTYH, a DNA repair enzyme, in the mitochondria of substantia nigra in Parkinson's disease.

Authors:  Takeo Arai; Jiro Fukae; Taku Hatano; Shin-ichiro Kubo; Toshio Ohtsubo; Yusaku Nakabeppu; Hideo Mori; Yoshikuni Mizuno; Nobutaka Hattori
Journal:  Acta Neuropathol       Date:  2006-06-14       Impact factor: 17.088

Review 5.  Mitochondrial dysfunction, oxidative stress and neurodegeneration.

Authors:  Michelangelo Mancuso; Fabio Coppede; Lucia Migliore; Gabriele Siciliano; Luigi Murri
Journal:  J Alzheimers Dis       Date:  2006-09       Impact factor: 4.472

6.  Melatonin protects against MPTP/MPP+ -induced mitochondrial DNA oxidative damage in vivo and in vitro.

Authors:  Liu-Ji Chen; Yan-Qin Gao; Xue-Jun Li; Di-Han Shen; Feng-Yan Sun
Journal:  J Pineal Res       Date:  2005-08       Impact factor: 13.007

7.  Distinct clustering of point mutations in mitochondrial DNA among patients with mitochondrial encephalomyopathies and with Parkinson's disease.

Authors:  T Ozawa; M Tanaka; H Ino; K Ohno; T Sano; Y Wada; M Yoneda; Y Tanno; T Miyatake; T Tanaka
Journal:  Biochem Biophys Res Commun       Date:  1991-04-30       Impact factor: 3.575

8.  Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.

Authors:  J Sian; D T Dexter; A J Lees; S Daniel; Y Agid; F Javoy-Agid; P Jenner; C D Marsden
Journal:  Ann Neurol       Date:  1994-09       Impact factor: 10.422

Review 9.  Oxidative mechanisms in nigral cell death in Parkinson's disease.

Authors:  P Jenner
Journal:  Mov Disord       Date:  1998       Impact factor: 10.338

10.  Alternative pathways for the in vivo repair of O6-alkylguanine and O4-alkylthymine in Escherichia coli: the adaptive response and nucleotide excision repair.

Authors:  L Samson; J Thomale; M F Rajewsky
Journal:  EMBO J       Date:  1988-07       Impact factor: 11.598

View more
  3 in total

1.  Genetic modification of H2AX renders mesenchymal stromal cell-derived dopamine neurons more resistant to DNA damage and subsequent apoptosis.

Authors:  Peizhou Jiang; Peng Huang; Shu-Hui Yen; Abba C Zubair; Dennis W Dickson
Journal:  Cytotherapy       Date:  2016-10-06       Impact factor: 5.414

2.  Activated or Impaired: An Overview of DNA Repair in Neurodegenerative Diseases.

Authors:  Nan Qin; Anke Geng; Renhao Xue
Journal:  Aging Dis       Date:  2022-07-11       Impact factor: 9.968

3.  Diabetes-induced central neuritic dystrophy and cognitive deficits are associated with the formation of oligomeric reticulon-3 via oxidative stress.

Authors:  Bei Zhao; Bai-Shen Pan; Su-Wen Shen; Xiao Sun; Zheng-Zhou Hou; Riqiang Yan; Feng-Yan Sun
Journal:  J Biol Chem       Date:  2013-04-16       Impact factor: 5.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.